SALIX PHARMACEUTICALS LTD Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability
SALIX PHARMACEUTICALS LTD had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability of $27.00 million as of 2014-03-31, per its 10-Q/A filed 2015-03-02.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability · last filed 2015-03-02
- 2014-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability $27.00M.
- 2014-01-02: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability $27.00M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability |
|---|---|
| 2014-03-31 | $27.00M 10-Q/A · filed 2015-03-02 |
| 2014-01-02 | $27.00M 10-Q/A · filed 2015-03-02 |